Our vision on the pharmaceutical and life sciences sector

Our life sciences leader, Thierry Vanwelkenhuyzen, shares his insights into this turbulent environment in the webcast above.

The pharmaceutical, biotech and medical device businesses are facing major challenges. Reorganising their business models, boosting R&D productivity, optimising manufacturing and restructuring their sales forces and more. Stakeholders such as shareholders, physicians, patients, payers and regulators are exerting pressure for change.